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Abstract: Bacterial cellulose (BC) is a biopolymer commonly used for wound dressing due to its
high biocompatible properties either in-vitro or in-vivo. The three-dimensional fiber structure of
BC becomes an advantage because it provides a template for the impregnation of materials in
order to improve BC’s properties as a wound dressing, since BC has not displayed any bioactivity
properties. In this study, micro-colloidal Zanthoxylum acanthopodium (MZA) fruit was loaded into BC
fibers via an in-situ method. Z. acanthopodium is known to have anti-inflammatory, antioxidant and
antimicrobial activities that can support BC to accelerate the wound healing process. The FTIR, XRD
and SEM analysis results showed that the loading process of MZA and the composite fabrication
were successfully carried out. The TGA test also showed that the presence of MZA in BC fibers
decreased Tmax composite from BC, from 357.8 to 334.5 ◦C for BC-MZA3. Other aspects, i.e., water
content, porosity, hemocompatibility and histology studies, also showed that the composite could
potentially be used as a wound dressing.
Keywords: bacterial cellulose; MZA; BC-MZA; composite; wound dressing
1. Introduction
Burned skin wound healing is a complex process that requires the involvement of tissues, cell types
and matrix components and time to heal [1]. Damaged skin areas are known to have a high risk of
attracting infectious bacteria, which affect the natural wound healing mechanism [2,3]. Therefore,
wound care with a wound dressing is essential for an effective healing process [4,5].
In order to accelerate the healing process, an active wound dressing was proposed in wound
management because the wound dressing that was commercially available, e.g., gauze, does not play
an active role in the wound healing process. Gauze was observed to potentially produce additional
trauma when it was released from the wound bed due to its dried material properties. It also did not
contain drugs that could help in reducing the time for wound closure. Meanwhile, an active wound
dressing is known to be able to meet several requirements of wound management, such as protecting
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wounds from infections during the healing process [6–8] as well as creating a supportive environment
for the regeneration of the epidermis for injured skin tissue by providing a barrier to prevent wound
infection, binding and controlling the release of drugs, absorbing the fluid produced from the wound
and reducing pain [8,9]. Previous studies have shown that films, hydrogels and foams formulated
from different biopolymers can be used to accomplish these functions [4,10].
Bacterial cellulose (BC), a cellulose that is produced by Acetobacter xylinum strain bacteria, is a
natural polymer that can be used in various biomedical applications. In addition to its purity, BC also has
other superior properties compared to plant-based cellulose. Bacterial cellulose has high crystallinity
due to its well-woven fiber structure, a high water-binding capability and biocompatibility [11–13].
Its high water-binding capability affects drug release controlling properties. This was reported through
previous research and it has become an advantage to apply BC as the base material in biomedical
applications, e.g., tissue engineering, blood vessel replacement, skin cell scaffolding and wound
dressing, due to its drug release controlling properties [8,14–17]. The indication that drugs or active
components can be trapped in BC films and released gradually was made apparent by the high number
of wrinkles that appeared after the drying process. Thus, dried BC can be used as a film matrix for the
slow release of active components [18,19].
Zanthoxylum acanthopodium fruit is known in Indonesia as andaliman. It is spicy in flavor and
commonly used to eliminate the smell of raw fish and meat. Z. acanthopodium is a wild plant that grows in
Tapanuli, North Sumatra, Indonesia, located at an altitude of 1500 m above sea level with a temperature
between 15 and 18 ◦C [20]. The shape of the fruit resembles a green pepper, but its green color turns
black when it dries. Previous studies confirmed that Z. acanthopodium fruit has anti-inflammatory,
antioxidant and antimicrobial abilities [21,22]. They also documented the antibacterial activity of
Z. acanthopodium fruit extracts against B. stearothermophilus, P. aeruginosa, V. cholera, E. coli, S. aureus and
Bacillus [20,23].
Therefore, it is necessary to conduct research to make BC-based wound dressings loaded with
micro-colloidal Z. acanthopodium (MZA) that can accelerate the wound healing process through
the improvement of BC fiber pores, antibacterial activity and bioactivity by providing drugs for
anti-inflammation. The formed composite was characterized and its potential as a wound dressing was
studied using scanning electron microscopy (SEM), Fourier-transform infrared spectroscopy (FTIR),
X-ray diffraction (XRD), thermogravimetric analysis (TGA), moisture content tests, porosity tests,
hemocompatibility assessments and in-vivo tests.
2. Materials and Methods
2.1. Materials
Acetobacter xylinum, the bacterial strain used in this research, was collected from the Polymer and
Material Lab, Chemistry Postgraduate, Universitas Sumatera Utara, Medan, Indonesia. Coconut water
and Z. acanthopodium fruit were purchased from a local market in Medan, Indonesia, while chemicals
such as glucose, urea, NaOH and glacial acetic acid were purchased from Merck (Damstadt, Germany).
2.2. Method
2.2.1. Production of MZA
Z. acanthopodium fruit was collected, sorted, washed and drained. Next, Z. acanthopodium fruit
was placed on paper and dried in an open space with no direct sunlight for around 10 days. MZA was
produced by crushing the dried Z. acanthopodium fruit using a high energy milling device (HEM) in
LIPI Serpong, Jakarta, Indonesia.
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2.2.2. In-Situ Fabrication of BC-Loaded MZA
Glucose (10 g/L) and urea (5 g/L) were supplemented to the coconut water as a source of carbon
and nitrogen, while glacial acetic acid (1 mL/L) was added later to adjust the medium pH to 5. Then,
5–25 g/L MZA was added into each flask to fabricate BC-MZA via an in-situ method. The medium and
MZA mixture was stirred for 20 min with a mechanical stirrer to ensure that it was well combined.
Then, it was sterilized in an autoclave. Finally, Acetobacter xylinum (0.1 v/v) was added to the medium
and it was inoculated for 8 days.
2.2.3. BC-MZA Composite Purification
The BC-MZA composite that floated on the top layer of the medium was harvested. Then, it was
washed with distilled water and immersed in 2.5% NaOH for 24 h, according to the purification process
performed by Gea et al. [24]. After 24 h, the BC-MZA composite was neutralized using aquadest and
dried in an oven at 40 ◦C. Each sample was labeled as shown in Table 1.
Table 1. Name and treatment variation for each sample.
Sample Name BC (g/L MZA)
BC-MZA1 5
BC-MZA2 10
BC-MZA3 15
BC-MZA4 20
BC-MZA5 25
2.2.4. Fourier-Transform Infrared Spectroscopy (FTIR)
Fourier-transform infrared spectroscopy (FTIR) characterization was done to determine the
biopolymer’s functional group. Samples were characterized using Bruker Platinum-ATR, Alpha in
wavelengths with a range of 4000 to 400 cm−1.
2.2.5. X-Ray Diffraction (XRD)
The X-ray diffraction (XRD) of the sample was studied by scanning a 2θ angle sample in a 7–70◦
range, using a Shimadzu XRD-6100 diffractometer. For further investigation, Equation (1) was used to
calculate the crystallinity index (CrI) for all samples.
Cr.I (%) =
Area of the crystalline
Area of total domain
· 100% (1)
2.2.6. Scanning Electron Microscopy (SEM)
The BC-MZA composites were characterized by using scanning electron microscopy (SEM) EDX
EVO MA Zeiss Bruker operated at 20 kV. The analysis was conducted by characterizing the surfaces
and layers in order to study the morphology of the composite that was formed.
2.2.7. Thermogravimetric Analysis (TGA)
Thermogravimetric analysis (TGA) and derivative thermogravimetric analysis (DTGA) were
carried out to characterize the thermal properties of the developed biopolymers. The thermal breakdown
of the samples was analyzed by using EXTAR 7300 series, with a temperature range of 30–600 ◦C,
under nitrogen gas conditions with a temperature rise of 10 ◦C/min.
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2.2.8. Moisture Content (Mc)
The moisture content of all samples was characterized by measuring the pure sample weight
and the freeze-dried sample weight. The ability of the samples to bind water was calculated using
Equation (2).
Mc (%) =
Weight wet samples−Weight dry sample
Weight wet samples
·100% (2)
2.2.9. Porosity Assessment
The porosity of the sample was studied by calculating the data using Equation (3). Data were
obtained by immersing the sample in 96% ethanol for 10 min.
Porosity (%) =
Initial volume of ethanol−Volume of ethanol after sample was taken
Volume of ethanol when sample was immersed− Volume of ethanol after sample was taken ·100% (3)
2.2.10. Hemocompatibility Test
The hemocompatibility test was done by washing the anticoagulant in horse blood with 0.9%
saline solution by centrifugation at 3000 rpm for 10 min. Then, the disk-shaped sample with an
8 mm diameter was immersed in a horse blood cell solution at 37 ◦C for 2 h by an agitation process.
Distilled water was used as a negative control while normal saline solution was used as a positive
control. A spectrophotometer was used to measure the absorbance of the samples at 540 nm. Finally,
the percentage of hemocompatibility was calculated by Equation (4).
Hemocompatibility (%) =
Samples absorbance−Negative control absorbance
Positive control absorbance− Negative control absorbance ·100% (4)
2.2.11. In-Vivo Test (Full-Thickness Burn Wound)
In order to test the efficacy of BC-MZA composites in accelerating the burn healing process,
an in-vivo test was performed on 28 male and female rats (Rattus norvegicus) aged 3 months, with
body weights of 150–180 g. The animal testing procedure performed in this study was approved by
the Animal Research Ethics Committees (AREC) No.0731/KEPH-FMIPA 2019 of Universitas Sumatera
Utara, Indonesia. All research processes were conducted in the animal research lab at Universitas
Sumatera Utara, following the university guidelines. The full-thickness burn wound was prepared first
by shaving the skin at the back area, where treatment would be given later. After this, the rats were
anesthetized using xylazine (5.0 mg/kg) and ketamine (35.0 mg/kg). Next, the skin area was cleaned
with chlorhexidine, povidone iodine and alcohol (70%). The full-thickness burn wound was made on
the cleaned area by placing a 20 × 20 mm rectangular piece of hot metal perpendicular (80 ◦C) to the
rat dorsum within one second, precisely at the position between the last thoracic vertebra and the first
sacrum. The rats were randomly divided into seven groups of 4, as follows: control (-), BC, BC-MZA1,
BC-MZA2, BC-MZA3, BC-MZA4 and BC-MZA5. The control (-) group did not receive any treatment.
In this test, BC and BC-MZA samples were used without dried treatment in order to minimize pain
and stimulate the healing process.
2.2.12. Wound Closure Assessment
Burns were observed every three days, from day 0 to day 21. The most significant changes in the
area of the wound were observed on days 7, 14 and 18. The wounds were measured using a caliper and
recorded by a camera. After this, the percentage of wound closure was calculated using Equation (5).
Wound Reduction (%) =
Wound Area Day 0−Wound Area Relative Day
Wound Area Day 0
·100% (5)
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2.2.13. Microbiological Examination
The burned skin area from the group of rats treated with bandaged (positive control), bioplacento,
BC-MZA3 and the group with no treatment (negative control) were swabbed on days 4, 8, 12 and 16
for bacterial analysis in the microbiology lab. Each sample was dissolved in 2 mL of normal saline and
subsequently vortexed in a 10-fold serial dilution. A volume of 1000 µL dilution of the sample was
spread and flattened on a tryptic soy agar (TSA) surface. The culture was left for 24 h in an incubator
at 37 ◦C, before the number of bacterial colonies were finally counted.
2.2.14. Histopathological Observation
After 21 days, all tissue areas treated were collected for histopathological observation. The samples
were set in 10% buffered formalin, prepared and coated in paraffin. The visualization of the
paraffin-embedded specimens was observed under microscopic light after cutting and marking
with Masson’s trichrome (MT) stains.
3. Results
3.1. FTIR BC-MZA Composites
The FTIR test results indicated in Figure 1 show that the three typical bands commonly found
in pure BC were the band at 3200-3700 cm−1, which indicated the presence of OH groups, the band
at 2900–2950 cm−1, which showed C-H bonds, and the band at 1050 cm−1, which assigned C-O
bonds [25,26]. These three bands were also observed in the BC-MZA composite spectra, as shown
in Figure 1b–f, but in slightly different peak intensities. In the BC-MZA composites, the intensity of
the OH band was observed to be higher. This is due to the presence of flavonoid groups that provide
antioxidant properties in Z. acanthopodium, which, in previous research, had been reported to be able
to prevent inflammatory reactions [20,21].
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Figure 1. FTIR spectra of (a) BC, (b) BC-MZA1, (c) BC-MZA2, (d) BC-MZA3, (e) BC-MZA4 and
(f) BC-MZA5.
3.2. XRD of BC-MZA Composites
The XRD t st results displayed in Figure 2 indicated that the addition of MZA in BC via the
in-situ technique still maintained the presence of the BC’s typical peaks in the omposit , which were
the peaks at 14◦ and 22◦ [27], but they were observed at lower intensities. As a result, the composite
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possessed a lower crystanility index (CrI). From the calculated XRD crystallographic plane, it can be
analyzed that the addition of 5 g/MZA in the BC-MZA1 sample possessed a CrI value of 73.30%, which
indicated that it had a lower peak intensity compared to the peak in the pure BC with a 82.88% CrI
value. The lowest peak intensity was seen in the addition of 10 g/L MZA with a CrI value of 70.27%.
The data are shown in Table 2. A decreasing trend in the CrI values of the composites was caused by
the existence of MZA trapped in the BC fibers, which is known to affect the arrangement of the fibers
in crystallization process. This is consistent with previous research which mentioned that the presence
of fillers in BC fibers would decrease the CrI value of the composite formed [28,29].
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Figure 2. X-Ray diffraction patterns of (a) BC, (b) BC-MZA1, (c) BC-MZA2, (d) BC-MZA3, (e) BC-MZA4
and (f) BC-MZA5.
Table 2. Crystallinity index (CrI) data of BC, BC-MZA1, BC-MZA2, BC-MZA3, BC-MZA4 and BC-MZA5.
Sample CrI (%)
BC 82.88
BC-MZA1 73.30
BC-MZA2 70.27
BC-MZA3 75.84
BC-MZA4 75.22
BC-MZA5 72.85
3.3. Morphology of BC-MZA Composite
The addition of active components into the BC fibers resulted in wrinkle formation in the BC-based
composites (Figure 3). This result is consistent with previous research, which showed that BC can be
used as a matrix film where trapped drugs or active components were characterized by observing the
creation of wrinkles after the drying process. This suggests that the BC matrix can handle the gradual
release of drugs or active components [18,19].
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A nanofiber structure can be seen from the SEM analysis imaging of neat BC, as shown in Figure 3b.
The addition of MZA into the medium showed that MZA was well-trapped in the BC fibers (Figure 3a).
The presence of MZA in the BC was observed to have interrupt d the fiber structure. This happened
beca se MZA was loaded into the BC fibers via in-situ methods and it disrupted the well-woven BC
synthesized by A. xylinum. These images correlated with the XRD data, which displayed a lower CrI
percentage in the composites than in the neat BC. The results indicated tha the in-situ fabrication of
BC-MZA composites can be carried out with good penetration of MZA into the BC fibers.
3.4. TGA/DTGA BC-MZA Composites
Based on the TGA and DTGA curves in Figure 4, the thermal degradation of BC occurred in three
stages. The first stage occurred at 30–110 ◦C, which could be assumed as the evaporation process of
the water contained in the BC. The second stage occurred at 220–390 ◦C, at which BC experienced
a major loss of mass during the thermal decomposition process. Then, the third stage occurred at
the 435–600 ◦C temperature range, which was known as the carbonization process [11]. From the
curves, these three stages of thermal breakdown were also experienced by the BC-MZA composites.
However, there were significant differences observed in the second stage. This stage took place at
the temperature range of 180–365 ◦C for the five composite variations. The remaining residues were
recorded at the end of the process for BC, BC-MZA1, BC-MZA2, BC-MZA3, BC-MZA4 and BC-MZA5,
with the respective results as follows: 27.98%, 12.96%, 13.32, 27.93%, 24.49% and 14.63% (Table 3).
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The DTGA curve shows that the maximum temp ratur in the thermal degradation stage with the
major loss of mass in BC occured at 357.8 ◦C. Meanwhile, t e peaks of the BC-MZA composite were
observed at 328.7, 332.5, 334.5 and 334.4 and 332.2 ◦C for BC-MZA1, BC-MZA2, BC-MZA3, BC-MZA4
and BC-MZA5, respectively, as listed i Table 3. This showed that the pr ence of MZA in the BC
fibers caused the composite o possess lower Tmax. This is consiste t wit the TGA curve, in which the
second stage experienced by the BC-MZA co posite was at 150–350 ◦C. This r sult may be correlated
with the presence of MZA in th fibers, which made thermal break own more easily experienced by
he natural product. In addition, the Tmax shift to lower temperatures was also ttributed to the lower
CrI percentag of the composit compared to the neat BC, since rI is one of the structural parameters
that affects thermal degradation [30].
Table 3. Onset temperature (◦C) and residual mass (%) data of BC, BC-MZA1, BC-MZA2, BC-MZA3,
BC-MZA4 and BC-MZA5.
Sample BC BC-MZA1 BC-MZA2 BC-MZA3 BC-MZA4 BC-MZA5
Tmax (◦C) 357.8 328.7 332.5 334.5 334.4 332.2
Residual mass (%) 27.98 13.08 13.32 27.93 24.49 14.63
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3.5. Moisture Content (%) and Porosity (%)
The results of the moisture content evaluation showed that the addition of MZA into the BC
fibers did not significantly affect the reduction in moisture content (Table 3). The moisture content
values for each sample were 98.9 ± 0.15, 97.8 ± 0.08, 97.5 ± 0.10, 96.7 ± 0.07, 96.5 ± 0.08 and 95.2 ± 0.05
for BC, BC-MZA1, BC-MZA2, BC-MZA3, BC-MZA4 and BC-MZA5, respectively. The results were
advantageous for the use of composites as wound dressings, because the moisture level affects the
adhesiveness of the wound dressing to the wound bed. The risk of injury can increase during the
removal of wound dressing in cases where it is too dry [7].
The addition of nanoherbal andaliman to BC was not known to significantly influence the decrease
in the porosity of the composites. The porosity values of the samples are presented in Table 3, and the
values for BC, BC-MZA1, BC-MZA2, BC-MZA3, BC-MZA4 and BC-MZA5 were 78.2 ± 0.13, 77.8 ± 0.08,
77.5 ± 0.02, 76.3 ± 0.05, 74.2 ± 0.06 and 73.9 ± 0.08, respectively.
3.6. Hemocompatibility (%)
The hemocompatibility test was conducted to investigate the percentage release of hemoglobin
into the plasma due to the damages in erythrocytes and analyze the biocompatibility properties of the
composites. Evaluation of six samples (Table 4 showed that there were five non-hemolytic samples,
with hemocompatibility (%) values between 0–2% for BC (1.52% ± 0.02%), BC-MZA1 (1.52% ± 0.01%),
BC-MZA2 (1.55% ± 0.03%), BC-MZA3 (1.58% ± 0.03%) and BC-MZA4 (1.7% ± 0.02%). Then, the sample
labelled as BC-MZA5 was considered to possess slightly hemolytic properties, with a hemolysis
percentage of 2.05% ± 0.05%. The results referred to the American Society for Testing and Materials
(ASTM F756-00, 2000) [31]. Therefore, the BC, BC-MZA1, BC-MZA2, BC-MZA3 and BC-MZA4 samples
proceeded to the in-vivo tests discussed in the next section, while BC-MZA5 was not tested since it
was classified as a slightly hemolytic material.
Table 4. Moisture content (%), porosity (%) and hemocompatibility (%) data of BC, BC-MZA1,
BC-MZA2, BC-MZA3, BC-MZA4 and BC-MZA5 (n = 4).
Sample Moisture Content (%) Porosity (%) Hemocompatibility (%)
BC 98.9 ± 0.15 78.2 ± 0.13 1.52 ± 0.02
BC-MZA1 97.8 ± 0.08 77.8 ± 0.08 1.52 ± 0.01
BC-MZA2 97.5 ± 0.10 77.5 ± 0.02 1.55 ± 0.03
BC-MZA3 96.7 ± 0.07 76.3 ± 0.05 1.58 ± 0.03
BC-MZA4 96.5 ± 0.08 74.2 ± 0.06 1.7 ± 0.02
BC-MZA5 95.2 ± 0.05 73.9 ± 0.08 2.05 ± 0.05
3.7. Microbiological Examination
A microbiological test was carried out on the wounds to confirm the presence of certain bacteria
and the ability of the wound dressing to inhibit bacterial growth. The data in Figure 5 show that the
composites were effective in slowing down bacterial growth in burns, in contrast to untreated wounds
(negative control), bandaged wounds (positive control) and bioplacenton-treated wounds. On day 16,
no bacteria were observed on the agar media from the treated groups using the BC-MZA3 composites,
while bacteria were observed in the negative control group (277 ± 8), positive control group (126 ± 5)
and bioplacenton-treated group (94 ± 7).
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3.8. In-Vivo Test of BC-MZA Composites
Wound Closure
Rats were used to assess the efficacy of BC-MZA composites to treat burns. From the seven groups
of rats that were tested, on day 7, each sample had a wound closure of 20.45% ± 2.22%, 29.45% ± 2.10%,
65.35% ± 1.10%, 58.65% ± 0.65%, 52.97% ± 0.7%, 47.63% ± 1.83% and 42.18% ± 3.05% for control (-),
BC, BC-MZA1, BC-MZA2, BC-MZA3, BC-MZA4 and BC-MZA5 controls, respectively. The largest
percentage of wound closure was observed in the group of rats treated with the BC-MZA1 composite.
The observation was carried out until day 18, when it was found that the group of rats treated with
BC-MZA3 had 97.70% ± 2.18% burn closures. Meanwhile, the remaining groups had experienced only
64.40% ± 1.50 %, 67.12% ± 2.70%, 89.02% ± 2.37%, 93.52% ± 0.80%, 92.03% ± 2.35%, and 90.15% ± 0.70%
wound closure for control (-), BC-MZA1, BC-MZA2, BC-MZA4 and BC-MZA5 controls, respectively
(Figure 6). The group which received BC-MZA1 treatment experienced the highest level of wound
closure on day 7 but only had a wound closure percentage of 89.02% ± 2.37% on day 18, because
there was a reduction in nanoherbal content. Therefore, the BC-MZA1 composite could not continue
to provide drugs during the wound healing process. From the observations, it could also be seen
that the group of rats treated with BC-MZA composites experienced a significant amount of healing
compared to the group of rats treated with the control (-) and BC. This is in line with a number of
studies which have suggested that a good wound dressing plays an active role in removing exudate
wounds, preserving the moisture in the area, promoting air circulation to the wound, possessing
antibacterial properties and providing drugs that can accelerate the wound healing process [4,5,10].
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3.9. Histopathological Observation
Histopathological observation (Figure 7a) was evaluated by an lyzing the re-epithelialization,
fibroblast immigration, inflammatory cell infiltration and connective tissue synthesis of the regenerated
tissues on the 18th day of burned skin. Healed burn skin tissue samples treated with the control (-)
were observed o have grown epidermis (stratified squamous epith lium), fibroblast cells and hair
follicles (-). Meanwhile, the tissues treated with BC exhibited discontinuous epithelial layers with
connective tissues, hair follicles and sebaceous glands (+). Moreover, wounds treated with BC-MZA1
were seen to have denser keratin, epidermis (stratifie squamous ithelium) and fibroblast cells.
This was due to the presence of antioxidants in MZA, which suppressed inflammatory cell infiltration
and accelerated the wound healing process [32]. In this sample, hair follicles and blood vessels were
found. This also i dicated tha MZA played an important role in the wound ealing process since it
could support vascularization. It is already known that vascularization can promote fibroblasts, bring
nutrition and supply macrophages and other monocytes which can manage low level inflammation
with anti-bacterial properties [33]. Compared to BC-MZA1 treatment, skin tissues treated with the
BC-MZA2 composite were observed to have no epithelial layer, hair follicles or sebaceous glands,
whereas skin tissues treated with the BC-MZA4 composite were observed to be almost without keratin,
epithelial layers (+) along the tissues, connective tissues consisting of collagen or fibroblast masses.
Meanwhile, burned skin tissues treated with the BC-MZA3 composite displayed the best wound
healing process among the samples. This was indicated by the complete formatting of epithelial layers
with connective tissues which were observed to mimic normal skin. This histopathological observation
was also supported by the granulation tissues of the burned skin in rats, as shown in the photographs,
which were harvested after 18 days. From the pictures, skin tissues treated with BC-MZA3 (Figure 7b)
appeared to have softer scars than the other skin tissues treated by other samples. In other words,
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based on our in-vivo observations, the granulation tissue of BC-MZA3 showed the best wound closure
performance among all samples.
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4. Conclusions
In conclusion, BC-MZA composites were successfully fabricated via an in-situ method. This is
supported by the characterization results obtained from FTIR, XRD, TGA/DTGA and SEM. BC-MZA
composites were also found to be potential materials for wound dressings, after moisture content,
porosity, hemocompatibility, microbiological assessment and in-vivo testing were conducted. In this
study, in-vivo testing showed that the composite with the 15 g/L MZA composition (BC-MZA3) was
the optimal composite to be applied as a wound dressing. Based on the histopathological observations,
the burned tissues treated with the BC-MZA3 composite displayed a complete formatted epithelial
layer and had softer scars in the granulation tissues. This study also found that the addition of 25 g/L
MZA (BC-MZA5) could not be recommended as a wound dressing, since the material produced was
classified as slightly hemolytic.
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